

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide biosynthetic process (GO:0009312) | 7.99680162 |
| 2 | male sex determination (GO:0030238) | 5.66182323 |
| 3 | T cell migration (GO:0072678) | 5.25843634 |
| 4 | negative thymic T cell selection (GO:0045060) | 5.16159151 |
| 5 | negative regulation of stress fiber assembly (GO:0051497) | 5.11334235 |
| 6 | negative T cell selection (GO:0043383) | 5.04874567 |
| 7 | mast cell activation involved in immune response (GO:0002279) | 5.03239147 |
| 8 | mast cell degranulation (GO:0043303) | 5.03239147 |
| 9 | energy homeostasis (GO:0097009) | 4.29963721 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.18862966 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.18862966 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.18578351 |
| 13 | thymic T cell selection (GO:0045061) | 4.14539672 |
| 14 | mast cell activation (GO:0045576) | 3.97938956 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.90487308 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89873561 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 3.82064610 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81084514 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.75308402 |
| 20 | regulation of histone H3-K27 methylation (GO:0061085) | 3.72549574 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67681678 |
| 22 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.63926838 |
| 23 | autophagic vacuole fusion (GO:0000046) | 3.63734782 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.61966134 |
| 25 | organelle membrane fusion (GO:0090174) | 3.58378696 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52497948 |
| 27 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49314507 |
| 28 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49314507 |
| 29 | interferon-gamma secretion (GO:0072643) | 3.41085689 |
| 30 | barbed-end actin filament capping (GO:0051016) | 3.39965120 |
| 31 | leukocyte degranulation (GO:0043299) | 3.35321045 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33843691 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.30494364 |
| 34 | T cell selection (GO:0045058) | 3.30086563 |
| 35 | positive T cell selection (GO:0043368) | 3.29019177 |
| 36 | positive regulation of macrophage differentiation (GO:0045651) | 3.25708359 |
| 37 | lymphocyte migration (GO:0072676) | 3.24875130 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22994464 |
| 39 | lymph node development (GO:0048535) | 3.21643544 |
| 40 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.13801818 |
| 41 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10254505 |
| 42 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.08552523 |
| 43 | hyaluronan catabolic process (GO:0030214) | 3.05541993 |
| 44 | response to interleukin-15 (GO:0070672) | 3.04654077 |
| 45 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.01488188 |
| 46 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.01377984 |
| 47 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.98330491 |
| 48 | negative regulation of glycogen metabolic process (GO:0070874) | 2.98124089 |
| 49 | leukocyte aggregation (GO:0070486) | 2.97896135 |
| 50 | positive regulation of fatty acid oxidation (GO:0046321) | 2.96420750 |
| 51 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95633511 |
| 52 | rRNA methylation (GO:0031167) | 2.94727684 |
| 53 | regulation of autophagic vacuole assembly (GO:2000785) | 2.93773883 |
| 54 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.92553841 |
| 55 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.91991356 |
| 56 | carnitine shuttle (GO:0006853) | 2.88959136 |
| 57 | histone H3-K36 demethylation (GO:0070544) | 2.88353983 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 2.86406613 |
| 59 | sex determination (GO:0007530) | 2.84701701 |
| 60 | negative regulation of macroautophagy (GO:0016242) | 2.82444196 |
| 61 | oligosaccharide metabolic process (GO:0009311) | 2.80565410 |
| 62 | leukocyte tethering or rolling (GO:0050901) | 2.78033833 |
| 63 | response to muramyl dipeptide (GO:0032495) | 2.77985824 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76761118 |
| 65 | tolerance induction (GO:0002507) | 2.75099672 |
| 66 | macroautophagy (GO:0016236) | 2.74032549 |
| 67 | maintenance of protein location in nucleus (GO:0051457) | 2.73726864 |
| 68 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.73169765 |
| 69 | negative regulation of innate immune response (GO:0045824) | 2.67039972 |
| 70 | negative regulation of lipid storage (GO:0010888) | 2.63639122 |
| 71 | natural killer cell differentiation (GO:0001779) | 2.62549182 |
| 72 | nucleotide transmembrane transport (GO:1901679) | 2.61975605 |
| 73 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.61358166 |
| 74 | zinc ion homeostasis (GO:0055069) | 2.60140239 |
| 75 | negative regulation of histone methylation (GO:0031061) | 2.59288286 |
| 76 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.58422697 |
| 77 | interferon-gamma production (GO:0032609) | 2.57521664 |
| 78 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.55325741 |
| 79 | positive regulation of T cell mediated immunity (GO:0002711) | 2.50999523 |
| 80 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.49998726 |
| 81 | positive regulation of cholesterol efflux (GO:0010875) | 2.49797425 |
| 82 | hepatocyte apoptotic process (GO:0097284) | 2.48734514 |
| 83 | positive regulation of glycogen metabolic process (GO:0070875) | 2.48561189 |
| 84 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.47922563 |
| 85 | diacylglycerol metabolic process (GO:0046339) | 2.47644559 |
| 86 | cellular zinc ion homeostasis (GO:0006882) | 2.45990264 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.45573855 |
| 88 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.42685619 |
| 89 | sleep (GO:0030431) | 2.42151074 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.42042998 |
| 91 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.40327953 |
| 92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.37880564 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.37331974 |
| 94 | neutrophil activation involved in immune response (GO:0002283) | 2.36400762 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 2.34195823 |
| 96 | regulation of T cell mediated immunity (GO:0002709) | 2.33957734 |
| 97 | biotin metabolic process (GO:0006768) | 2.33915435 |
| 98 | protein K11-linked deubiquitination (GO:0035871) | 2.30717969 |
| 99 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.30093094 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.30077440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.37166071 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06292401 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.19740509 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.02415444 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.82963050 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.80243681 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67204216 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.62341457 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.61628281 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58286624 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.54096472 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51607991 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.47845738 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.45276792 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36545269 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.30594869 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26659586 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.21208343 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20993251 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.18445221 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.15615581 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13633158 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09785167 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.06229926 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03629683 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98499471 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97726404 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95311615 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94962802 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89593256 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86178852 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83615116 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81201770 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72426443 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72072323 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68731380 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66883979 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65960195 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63740508 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63260976 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62950532 |
| 42 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.62585352 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59063360 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57134871 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56152763 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55574778 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51397923 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49997951 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48204624 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47252031 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.47110094 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43326575 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41983371 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40406350 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39056898 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37809502 |
| 57 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.35662545 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35485973 |
| 59 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34456913 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33333910 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32679772 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31208885 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29877057 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28155135 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26791590 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24702455 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23895570 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23790275 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23484578 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22041138 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18463080 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18022714 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16096208 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15382571 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15358471 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13708716 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13163475 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12348886 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12001796 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11457430 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11270935 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10435966 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10435966 |
| 84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10115736 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09847173 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09083076 |
| 87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07548019 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05863020 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04476091 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03256007 |
| 91 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01207412 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98825012 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98530548 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98372263 |
| 95 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97358210 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96620580 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96440793 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.96341935 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95834054 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94194798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.24401480 |
| 2 | MP0005671_abnormal_response_to | 3.76490611 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.70753464 |
| 4 | MP0009840_abnormal_foam_cell | 3.60140825 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.22527900 |
| 6 | MP0003724_increased_susceptibility_to | 3.12092243 |
| 7 | MP0000685_abnormal_immune_system | 2.53956926 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.38469004 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.31649295 |
| 10 | MP0003195_calcinosis | 2.27771643 |
| 11 | MP0001800_abnormal_humoral_immune | 2.24530179 |
| 12 | MP0003436_decreased_susceptibility_to | 2.15362595 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.11900746 |
| 14 | MP0004381_abnormal_hair_follicle | 2.08126714 |
| 15 | MP0002723_abnormal_immune_serum | 2.04614603 |
| 16 | MP0002452_abnormal_antigen_presenting | 1.99920718 |
| 17 | MP0001819_abnormal_immune_cell | 1.99778417 |
| 18 | MP0002420_abnormal_adaptive_immunity | 1.98184403 |
| 19 | MP0002405_respiratory_system_inflammati | 1.93031694 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.89763876 |
| 21 | MP0005025_abnormal_response_to | 1.86030658 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.85255396 |
| 23 | MP0002419_abnormal_innate_immunity | 1.75480314 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.75157443 |
| 25 | MP0009785_altered_susceptibility_to | 1.73458328 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.73196718 |
| 27 | MP0005387_immune_system_phenotype | 1.70385821 |
| 28 | MP0001790_abnormal_immune_system | 1.70385821 |
| 29 | MP0003828_pulmonary_edema | 1.63529673 |
| 30 | MP0005310_abnormal_salivary_gland | 1.62110408 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.62069849 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.56231708 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.54310291 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.54139097 |
| 35 | MP0002398_abnormal_bone_marrow | 1.52644798 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.51192154 |
| 37 | MP0000716_abnormal_immune_system | 1.50596994 |
| 38 | MP0004947_skin_inflammation | 1.49778527 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.44385324 |
| 40 | MP0004272_abnormal_basement_membrane | 1.44305241 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.43595427 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.41930283 |
| 43 | MP0002722_abnormal_immune_system | 1.41426904 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.38212750 |
| 45 | MP0005647_abnormal_sex_gland | 1.32948095 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.25369952 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.25319129 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.25177225 |
| 49 | MP0002933_joint_inflammation | 1.24080469 |
| 50 | MP0002429_abnormal_blood_cell | 1.20861146 |
| 51 | MP0003091_abnormal_cell_migration | 1.19797191 |
| 52 | MP0006082_CNS_inflammation | 1.18638899 |
| 53 | MP0001873_stomach_inflammation | 1.15698296 |
| 54 | MP0000858_altered_metastatic_potential | 1.15200655 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.12208253 |
| 56 | MP0008004_abnormal_stomach_pH | 1.06292656 |
| 57 | MP0002006_tumorigenesis | 1.05631606 |
| 58 | MP0003315_abnormal_perineum_morphology | 1.03663354 |
| 59 | MP0003045_fibrosis | 1.03211980 |
| 60 | MP0005390_skeleton_phenotype | 1.02178121 |
| 61 | MP0002168_other_aberrant_phenotype | 1.01150190 |
| 62 | MP0009278_abnormal_bone_marrow | 1.00343713 |
| 63 | MP0005451_abnormal_body_composition | 1.00150394 |
| 64 | MP0003866_abnormal_defecation | 0.98700001 |
| 65 | MP0001849_ear_inflammation | 0.97205002 |
| 66 | MP0005166_decreased_susceptibility_to | 0.96377555 |
| 67 | MP0003136_yellow_coat_color | 0.92041141 |
| 68 | MP0003959_abnormal_lean_body | 0.91215249 |
| 69 | MP0010329_abnormal_lipoprotein_level | 0.90074049 |
| 70 | MP0003303_peritoneal_inflammation | 0.89907171 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 0.89263062 |
| 72 | MP0004233_abnormal_muscle_weight | 0.88938401 |
| 73 | MP0001661_extended_life_span | 0.88553153 |
| 74 | MP0009764_decreased_sensitivity_to | 0.87890359 |
| 75 | MP0004130_abnormal_muscle_cell | 0.87588296 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.87161211 |
| 77 | MP0008469_abnormal_protein_level | 0.86597913 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 0.86446066 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.85065757 |
| 80 | MP0000249_abnormal_blood_vessel | 0.84960201 |
| 81 | MP0003795_abnormal_bone_structure | 0.84847899 |
| 82 | MP0002090_abnormal_vision | 0.84601198 |
| 83 | MP0002132_abnormal_respiratory_system | 0.84508965 |
| 84 | MP0005365_abnormal_bile_salt | 0.83503430 |
| 85 | MP0003879_abnormal_hair_cell | 0.81474830 |
| 86 | MP0000747_muscle_weakness | 0.78260267 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.78247202 |
| 88 | MP0005448_abnormal_energy_balance | 0.77401565 |
| 89 | MP0001243_abnormal_dermal_layer | 0.76476952 |
| 90 | MP0000490_abnormal_crypts_of | 0.75040365 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.73746385 |
| 92 | MP0003646_muscle_fatigue | 0.72461553 |
| 93 | MP0000343_altered_response_to | 0.71474650 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.70213877 |
| 95 | MP0002163_abnormal_gland_morphology | 0.70097261 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.69953990 |
| 97 | MP0003075_altered_response_to | 0.69778279 |
| 98 | MP0003448_altered_tumor_morphology | 0.69743637 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.68200439 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.65551446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thoracic kyphosis (HP:0002942) | 5.41532761 |
| 2 | Abnormality of the thoracic spine (HP:0100711) | 4.09536879 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 3.64185640 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 3.63843268 |
| 5 | T lymphocytopenia (HP:0005403) | 3.60070120 |
| 6 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.52003703 |
| 7 | Abnormality of the lumbar spine (HP:0100712) | 3.50765917 |
| 8 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.44651932 |
| 9 | Nonimmune hydrops fetalis (HP:0001790) | 3.35497484 |
| 10 | Global brain atrophy (HP:0002283) | 3.35218298 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.30257353 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.23212886 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.22551555 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.22551555 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.22551555 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.13375171 |
| 17 | Combined immunodeficiency (HP:0005387) | 3.11753004 |
| 18 | Abnormal protein glycosylation (HP:0012346) | 2.95958226 |
| 19 | Abnormal glycosylation (HP:0012345) | 2.95958226 |
| 20 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.95958226 |
| 21 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.95958226 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88308434 |
| 23 | Vascular calcification (HP:0004934) | 2.82929929 |
| 24 | Mucopolysacchariduria (HP:0008155) | 2.70060970 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70060970 |
| 26 | Renal cortical cysts (HP:0000803) | 2.69721822 |
| 27 | J-shaped sella turcica (HP:0002680) | 2.67098459 |
| 28 | Dysostosis multiplex (HP:0000943) | 2.64427020 |
| 29 | Abnormality of the frontal sinuses (HP:0002687) | 2.64383911 |
| 30 | Abnormality of the columella (HP:0009929) | 2.61126714 |
| 31 | Cardiovascular calcification (HP:0011915) | 2.59608217 |
| 32 | Beaking of vertebral bodies (HP:0004568) | 2.58425725 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.56262639 |
| 34 | Abnormality of T cells (HP:0002843) | 2.53560624 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.52875833 |
| 36 | Retinal atrophy (HP:0001105) | 2.50866323 |
| 37 | Protruding tongue (HP:0010808) | 2.48816702 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.45575882 |
| 39 | Self-mutilation (HP:0000742) | 2.44961524 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44816407 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.43711585 |
| 42 | Thickened calvaria (HP:0002684) | 2.38134789 |
| 43 | Spondylolisthesis (HP:0003302) | 2.35114066 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.33907840 |
| 45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33329527 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33329527 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33329527 |
| 48 | Persistence of primary teeth (HP:0006335) | 2.31635548 |
| 49 | Alopecia of scalp (HP:0002293) | 2.28118802 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.27509758 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25124581 |
| 52 | Granulocytopenia (HP:0001913) | 2.23838993 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.21437556 |
| 54 | Gonadal dysgenesis (HP:0000133) | 2.20269843 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.20059686 |
| 56 | Anhidrosis (HP:0000970) | 2.19022122 |
| 57 | Abnormality of the pericardium (HP:0001697) | 2.18289219 |
| 58 | Poor head control (HP:0002421) | 2.16547980 |
| 59 | Recurrent viral infections (HP:0004429) | 2.15475549 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.14058072 |
| 61 | Recurrent corneal erosions (HP:0000495) | 2.13978195 |
| 62 | Cheilitis (HP:0100825) | 2.11867234 |
| 63 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.11740924 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 2.11141644 |
| 65 | Large for gestational age (HP:0001520) | 2.06902054 |
| 66 | Pustule (HP:0200039) | 2.05517254 |
| 67 | Eosinophilia (HP:0001880) | 2.04628983 |
| 68 | Capillary hemangiomas (HP:0005306) | 2.04231009 |
| 69 | Myositis (HP:0100614) | 2.02710334 |
| 70 | Polymicrogyria (HP:0002126) | 2.01818648 |
| 71 | Cortical dysplasia (HP:0002539) | 2.00710565 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99305275 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99305275 |
| 74 | Thoracolumbar scoliosis (HP:0002944) | 1.97059555 |
| 75 | Brushfield spots (HP:0001088) | 1.93925801 |
| 76 | Follicular hyperkeratosis (HP:0007502) | 1.89444912 |
| 77 | Colitis (HP:0002583) | 1.88651195 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 1.87674635 |
| 79 | Mitral stenosis (HP:0001718) | 1.87159425 |
| 80 | Inflammation of the large intestine (HP:0002037) | 1.86852715 |
| 81 | Abnormality of dental color (HP:0011073) | 1.86478961 |
| 82 | Ureteral duplication (HP:0000073) | 1.85853078 |
| 83 | Arterial thrombosis (HP:0004420) | 1.85847293 |
| 84 | Seborrheic dermatitis (HP:0001051) | 1.85162256 |
| 85 | Epistaxis (HP:0000421) | 1.84023871 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 1.83545024 |
| 87 | Optic neuritis (HP:0100653) | 1.83545024 |
| 88 | Deformed sella turcica (HP:0002681) | 1.83011708 |
| 89 | Intellectual disability, progressive (HP:0006887) | 1.82476213 |
| 90 | Protuberant abdomen (HP:0001538) | 1.80589396 |
| 91 | Conical tooth (HP:0000698) | 1.79830257 |
| 92 | Slow saccadic eye movements (HP:0000514) | 1.76993637 |
| 93 | Abnormal number of erythroid precursors (HP:0012131) | 1.76540918 |
| 94 | Pulmonary infiltrates (HP:0002113) | 1.74145085 |
| 95 | Craniofacial hyperostosis (HP:0004493) | 1.73843344 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 1.71662578 |
| 97 | Abnormality of the sella turcica (HP:0002679) | 1.70399698 |
| 98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70100431 |
| 99 | Chronic diarrhea (HP:0002028) | 1.69636963 |
| 100 | Bulbar palsy (HP:0001283) | 1.68931143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.55907201 |
| 2 | INSRR | 4.30235500 |
| 3 | MUSK | 4.10615164 |
| 4 | MAP3K10 | 3.20661646 |
| 5 | ARAF | 3.20044837 |
| 6 | IRAK4 | 2.98688071 |
| 7 | MAP3K13 | 2.93585426 |
| 8 | ZAP70 | 2.66124217 |
| 9 | IRAK3 | 2.42807440 |
| 10 | BLK | 2.39717437 |
| 11 | GRK6 | 2.33090421 |
| 12 | TLK1 | 1.96471071 |
| 13 | TAOK3 | 1.82247020 |
| 14 | LATS1 | 1.80864713 |
| 15 | MAP4K1 | 1.73870404 |
| 16 | PIM2 | 1.67820712 |
| 17 | MAP3K14 | 1.64832738 |
| 18 | CDK12 | 1.61395153 |
| 19 | TXK | 1.54888578 |
| 20 | MAPKAPK3 | 1.49428758 |
| 21 | BMPR2 | 1.43415799 |
| 22 | MAP2K2 | 1.43200281 |
| 23 | TRIB3 | 1.35088856 |
| 24 | MAP3K9 | 1.25966519 |
| 25 | FES | 1.25434911 |
| 26 | EEF2K | 1.21532605 |
| 27 | CSF1R | 1.17633484 |
| 28 | EPHB1 | 1.13793340 |
| 29 | PRKCQ | 1.08367716 |
| 30 | NLK | 1.07735872 |
| 31 | PASK | 1.07334096 |
| 32 | MST4 | 1.07041735 |
| 33 | EPHA3 | 1.06264459 |
| 34 | PDGFRB | 1.05670195 |
| 35 | SYK | 1.04411286 |
| 36 | TBK1 | 1.02015502 |
| 37 | RAF1 | 0.99477085 |
| 38 | MATK | 0.97788782 |
| 39 | CSK | 0.97608107 |
| 40 | MELK | 0.95873348 |
| 41 | CAMKK2 | 0.93953685 |
| 42 | STK38 | 0.93844977 |
| 43 | MAP3K4 | 0.93842913 |
| 44 | BTK | 0.93232437 |
| 45 | PINK1 | 0.91769706 |
| 46 | IKBKB | 0.86088546 |
| 47 | KIT | 0.84612514 |
| 48 | LIMK1 | 0.82661448 |
| 49 | CAMK1D | 0.82514949 |
| 50 | JAK1 | 0.80282354 |
| 51 | CAMKK1 | 0.77785765 |
| 52 | ITK | 0.75721871 |
| 53 | CLK1 | 0.72105551 |
| 54 | MET | 0.71906001 |
| 55 | ICK | 0.70803372 |
| 56 | MAP3K1 | 0.70101900 |
| 57 | KSR2 | 0.70089357 |
| 58 | BMX | 0.69793792 |
| 59 | TAOK1 | 0.69363100 |
| 60 | CDK3 | 0.68161431 |
| 61 | JAK3 | 0.66408938 |
| 62 | BRAF | 0.66286077 |
| 63 | MST1R | 0.66007658 |
| 64 | PAK2 | 0.65345116 |
| 65 | STK38L | 0.65145067 |
| 66 | CDK4 | 0.63813618 |
| 67 | MARK3 | 0.63031886 |
| 68 | LCK | 0.62584141 |
| 69 | RIPK4 | 0.60959354 |
| 70 | PTK2B | 0.60942600 |
| 71 | SCYL2 | 0.58942094 |
| 72 | FGR | 0.58508455 |
| 73 | RPS6KA5 | 0.58497110 |
| 74 | MOS | 0.56913218 |
| 75 | NEK9 | 0.54467701 |
| 76 | RET | 0.53689538 |
| 77 | HCK | 0.53590090 |
| 78 | TAOK2 | 0.52036757 |
| 79 | LYN | 0.51938859 |
| 80 | MAP2K7 | 0.50220726 |
| 81 | RPS6KA4 | 0.50178380 |
| 82 | PBK | 0.48555249 |
| 83 | TESK1 | 0.44295578 |
| 84 | TRPM7 | 0.42705409 |
| 85 | RPS6KA6 | 0.42094647 |
| 86 | CDK6 | 0.40420808 |
| 87 | CHUK | 0.38519436 |
| 88 | PRPF4B | 0.37965121 |
| 89 | RPS6KA2 | 0.36960248 |
| 90 | FGFR4 | 0.36083350 |
| 91 | ADRBK1 | 0.35836627 |
| 92 | SIK1 | 0.34582212 |
| 93 | MAPK11 | 0.33883690 |
| 94 | VRK2 | 0.32652590 |
| 95 | EPHA2 | 0.31475956 |
| 96 | MAP3K8 | 0.29634721 |
| 97 | IGF1R | 0.29482754 |
| 98 | NEK2 | 0.29454928 |
| 99 | IKBKE | 0.29425783 |
| 100 | DAPK2 | 0.28625239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.94536922 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.28269926 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.88769220 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.79781975 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.78952602 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.62631492 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.60046146 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.47237760 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.47152174 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14863633 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74433209 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72947572 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.72917732 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62654361 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.50064133 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.50062187 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48406274 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47732096 |
| 19 | Apoptosis_Homo sapiens_hsa04210 | 1.43856870 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41347904 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.36075867 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32510010 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26004448 |
| 24 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24021121 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23635123 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23615212 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19676285 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17534829 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.16554821 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.16386987 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16053050 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.11147360 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10031436 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.07586678 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.06142293 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04784182 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.04179863 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99991694 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 0.99824073 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 0.96415034 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93402123 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93334513 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92104057 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92028990 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91757108 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90965052 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88658068 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88281545 |
| 49 | Prostate cancer_Homo sapiens_hsa05215 | 0.87500154 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85740392 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84899627 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84395617 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78866345 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76939632 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76919866 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75335266 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74526426 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73942428 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73547699 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72824037 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71154813 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.70583844 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69027286 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68658624 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68621842 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67902653 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67058251 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.65753461 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.64561838 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64550863 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64274805 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.59358588 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59323562 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.55065598 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53570578 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51685459 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50655519 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.50203999 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.50140559 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49843385 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49725498 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49248663 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48586467 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42820303 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42436181 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41840839 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39796817 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39705081 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39332245 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39165542 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39133527 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38542971 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38194093 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37702613 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37677893 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37322248 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34948858 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34832616 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33753387 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31492890 |

